RIGL vs STE · P/E 9.1, rev $179.3M vs P/E 25, rev $5.46B
Rigel Pharmaceuticals Inc (RIGL) versus STERIS plc (STE) — a side-by-side from cached financials, not a winner call.
Rigel Pharmaceuticals Inc (RIGL) is a biotechnology company listed on US.
STERIS plc (STE) is a medical devices company listed on NYSE.
Latest reported RIGL revenue for 2024-12-31 was $179.3M. Net income was $17.5M. Revenue was up 53.4% from 2023-12-31 to 2024-12-31. RIGL currently screens at market cap $338.3M and trailing P/E 9.1.
Latest reported STE revenue for 2025-03-31 was $5.46B. Net income was $616.1M. Revenue was up 284.6% from 2024-03-31 to 2025-03-31. STE currently screens at market cap $19.43B and trailing P/E 25.1.
RIGL currently screens at market cap $338.3M and trailing P/E 9.1. STE currently screens at market cap $19.43B and trailing P/E 25.1.
Not investment advice. Open the RIGL and STE stock pages for the full models.
Not investment advice.